- call +1-201-465-4211
- email sales@mrinsights.biz
In vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early stages of the development of potentially useful new substances such as therapeutic drugs, agricultural chemicals and food additives.
Scope of the Report:
This report studies the In Vitro Toxicology Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the In Vitro Toxicology Testing market by product type and applications/end industries.
Europe is projected to account for the largest share of the global market. The demand for in vitro toxicology testing in Europe is driven by the increasing number of investments in research and innovation by the European Commission to develop alternative methods to animal testing. The European Union has been a leader in supporting research to advance the development and validation of in vitro toxicology testing protocols for regulatory purposes.
The global In Vitro Toxicology Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of In Vitro Toxicology Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
SGS
Covance
Bio-Rad Laboratories
Qiagen
GE Healthcare
Eurofins Scientific
Merck
Thermo Fisher
Charles River Laboratories International
Catalent
Cyprotex
Promega
Gentronix Limited
Ascendance Biotechnology
MB Research Laboratories
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cell culture technology
High-throughput technology
Cellular imaging technology
Toxicogenomics
Market Segment by Applications, can be divided into
Pharmaceuticals & biopharmaceuticals industry
Cosmetics and household products industry
Food industry
Chemicals industry
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 In Vitro Toxicology Testing Market Overview
1.1 Product Overview and Scope of In Vitro Toxicology Testing
1.2 Classification of In Vitro Toxicology Testing by Types
1.2.1 Global In Vitro Toxicology Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global In Vitro Toxicology Testing Revenue Market Share by Types in 2017
1.2.3 Cell culture technology
1.2.4 High-throughput technology
1.2.5 Cellular imaging technology
1.2.6 Toxicogenomics
1.3 Global In Vitro Toxicology Testing Market by Application
1.3.1 Global In Vitro Toxicology Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Pharmaceuticals & biopharmaceuticals industry
1.3.3 Cosmetics and household products industry
1.3.4 Food industry
1.3.5 Chemicals industry
1.4 Global In Vitro Toxicology Testing Market by Regions
1.4.1 Global In Vitro Toxicology Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) In Vitro Toxicology Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) In Vitro Toxicology Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) In Vitro Toxicology Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) In Vitro Toxicology Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) In Vitro Toxicology Testing Status and Prospect (2013-2023)
1.5 Global Market Size of In Vitro Toxicology Testing (2013-2023)
2 Manufacturers Profiles
2.1 SGS
2.1.1 Business Overview
2.1.2 In Vitro Toxicology Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 SGS In Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Covance
2.2.1 Business Overview
2.2.2 In Vitro Toxicology Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Covance In Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bio-Rad Laboratories
2.3.1 Business Overview
2.3.2 In Vitro Toxicology Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bio-Rad Laboratories In Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Qiagen
2.4.1 Business Overview
2.4.2 In Vitro Toxicology Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Qiagen In Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 GE Healthcare
2.5.1 Business Overview
2.5.2 In Vitro Toxicology Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GE Healthcare In Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eurofins Scientific
2.6.1 Business Overview
2.6.2 In Vitro Toxicology Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eurofins Scientific In Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 In Vitro Toxicology Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck In Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Thermo Fisher
2.8.1 Business Overview
2.8.2 In Vitro Toxicology Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Thermo Fisher In Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Charles River Laboratories International
2.9.1 Business Overview
2.9.2 In Vitro Toxicology Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Charles River Laboratories International In Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Catalent
2.10.1 Business Overview
2.10.2 In Vitro Toxicology Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Catalent In Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.11 Cyprotex
2.11.1 Business Overview
2.11.2 In Vitro Toxicology Testing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Cyprotex In Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.12 Promega
2.12.1 Business Overview
2.12.2 In Vitro Toxicology Testing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Promega In Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.13 Gentronix Limited
2.13.1 Business Overview
2.13.2 In Vitro Toxicology Testing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Gentronix Limited In Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.14 Ascendance Biotechnology
2.14.1 Business Overview
2.14.2 In Vitro Toxicology Testing Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Ascendance Biotechnology In Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
2.15 MB Research Laboratories
2.15.1 Business Overview
2.15.2 In Vitro Toxicology Testing Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 MB Research Laboratories In Vitro Toxicology Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global In Vitro Toxicology Testing Market Competition, by Players
3.1 Global In Vitro Toxicology Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 In Vitro Toxicology Testing Players Market Share
3.2.2 Top 10 In Vitro Toxicology Testing Players Market Share
3.3 Market Competition Trend
4 Global In Vitro Toxicology Testing Market Size by Regions
4.1 Global In Vitro Toxicology Testing Revenue and Market Share by Regions
4.2 North America In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
4.3 Europe In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
4.5 South America In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
5 North America In Vitro Toxicology Testing Revenue by Countries
5.1 North America In Vitro Toxicology Testing Revenue by Countries (2013-2018)
5.2 USA In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
5.3 Canada In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
6 Europe In Vitro Toxicology Testing Revenue by Countries
6.1 Europe In Vitro Toxicology Testing Revenue by Countries (2013-2018)
6.2 Germany In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
6.3 UK In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
6.4 France In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
6.5 Russia In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
6.6 Italy In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific In Vitro Toxicology Testing Revenue by Countries
7.1 Asia-Pacific In Vitro Toxicology Testing Revenue by Countries (2013-2018)
7.2 China In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
7.3 Japan In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
7.4 Korea In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
7.5 India In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
8 South America In Vitro Toxicology Testing Revenue by Countries
8.1 South America In Vitro Toxicology Testing Revenue by Countries (2013-2018)
8.2 Brazil In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue In Vitro Toxicology Testing by Countries
9.1 Middle East and Africa In Vitro Toxicology Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
9.3 UAE In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa In Vitro Toxicology Testing Revenue and Growth Rate (2013-2018)
10 Global In Vitro Toxicology Testing Market Segment by Type
10.1 Global In Vitro Toxicology Testing Revenue and Market Share by Type (2013-2018)
10.2 Global In Vitro Toxicology Testing Market Forecast by Type (2018-2023)
10.3 Cell culture technology Revenue Growth Rate (2013-2023)
10.4 High-throughput technology Revenue Growth Rate (2013-2023)
10.5 Cellular imaging technology Revenue Growth Rate (2013-2023)
10.6 Toxicogenomics Revenue Growth Rate (2013-2023)
11 Global In Vitro Toxicology Testing Market Segment by Application
11.1 Global In Vitro Toxicology Testing Revenue Market Share by Application (2013-2018)
11.2 In Vitro Toxicology Testing Market Forecast by Application (2018-2023)
11.3 Pharmaceuticals & biopharmaceuticals industry Revenue Growth (2013-2018)
11.4 Cosmetics and household products industry Revenue Growth (2013-2018)
11.5 Food industry Revenue Growth (2013-2018)
11.6 Chemicals industry Revenue Growth (2013-2018)
12 Global In Vitro Toxicology Testing Market Size Forecast (2018-2023)
12.1 Global In Vitro Toxicology Testing Market Size Forecast (2018-2023)
12.2 Global In Vitro Toxicology Testing Market Forecast by Regions (2018-2023)
12.3 North America In Vitro Toxicology Testing Revenue Market Forecast (2018-2023)
12.4 Europe In Vitro Toxicology Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific In Vitro Toxicology Testing Revenue Market Forecast (2018-2023)
12.6 South America In Vitro Toxicology Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa In Vitro Toxicology Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure In Vitro Toxicology Testing Picture
Table Product Specifications of In Vitro Toxicology Testing
Table Global In Vitro Toxicology Testing and Revenue (Million USD) Ma
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
